Endophthalmitis after intravitreal injections

Stephen G. Schwartz; Harry W. Flynn; Ingrid U. Scott

doi:10.1517/14656560903081752

Endophthalmitis after intravitreal injections

Stephen G. Schwartz
, Harry W. Flynn
, Ingrid U. Scott

Research output: Contribution to journal › Review article › peer-review

41 Scopus citations

Abstract

Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

Original language	English (US)
Pages (from-to)	2119-2126
Number of pages	8
Journal	Expert Opinion on Pharmacotherapy
Volume	10
Issue number	13
DOIs	https://doi.org/10.1517/14656560903081752
State	Published - Sep 2009

All Science Journal Classification (ASJC) codes

Pharmacology
Pharmacology (medical)

Access to Document

10.1517/14656560903081752

Cite this

@article{10c1866c12bc4f4887efb22625df47d6,

title = "Endophthalmitis after intravitreal injections",

abstract = "Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.",

author = "Schwartz, \{Stephen G.\} and Flynn, \{Harry W.\} and Scott, \{Ingrid U.\}",

note = "Funding Information: This paper was partially supported by NIH center grant P30-EY014801 and by an unrestricted grant to the University of Miami from Research to Prevent Blindness, New York. SG Schwartz has received research funding from Genentech, owns equity in Pfizer and is co-holder of a patent pending entitled {\textquoteleft}Molecular targets for modulating intraocular pressure and differentiation of steroid responders versus nonresponders{\textquoteright}. The other two authors declare no conflicts of interest.",

year = "2009",

month = sep,

doi = "10.1517/14656560903081752",

language = "English (US)",

volume = "10",

pages = "2119--2126",

journal = "Expert Opinion on Pharmacotherapy",

issn = "1465-6566",

publisher = "Taylor and Francis Ltd.",

number = "13",

}

TY - JOUR

T1 - Endophthalmitis after intravitreal injections

AU - Schwartz, Stephen G.

AU - Flynn, Harry W.

AU - Scott, Ingrid U.

N1 - Funding Information: This paper was partially supported by NIH center grant P30-EY014801 and by an unrestricted grant to the University of Miami from Research to Prevent Blindness, New York. SG Schwartz has received research funding from Genentech, owns equity in Pfizer and is co-holder of a patent pending entitled ‘Molecular targets for modulating intraocular pressure and differentiation of steroid responders versus nonresponders’. The other two authors declare no conflicts of interest.

PY - 2009/9

Y1 - 2009/9

N2 - Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

AB - Endophthalmitis following intravitreal injection is an infrequent but serious clinical problem. Infectious endophthalmitis must be differentiated from noninfectious inflammation. Depending on the series, the risk of endophthalmitis is very low. The use of a standardized injection protocol can reduce the risk of infection.

UR - https://www.scopus.com/pages/publications/68949141615

UR - https://www.scopus.com/pages/publications/68949141615#tab=citedBy

U2 - 10.1517/14656560903081752

DO - 10.1517/14656560903081752

M3 - Review article

C2 - 19586422

AN - SCOPUS:68949141615

SN - 1465-6566

VL - 10

SP - 2119

EP - 2126

JO - Expert Opinion on Pharmacotherapy

JF - Expert Opinion on Pharmacotherapy

IS - 13

ER -

Endophthalmitis after intravitreal injections

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this